Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin Prices
02:34pm, Friday, 20'th Aug 2021
House Energy & Commerce Committee leaders sent three letters to execs at Eli Lilly And Co (NYSE: LLY), Sanofi SA (NASDAQ: SNY), and Novo Nordisk A/S (NYSE: NVO), raising concerns that despite
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now
05:52am, Thursday, 19'th Aug 2021
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.
Inside Sanofi's $3.2B Translate Bio Buyout
04:19pm, Monday, 16'th Aug 2021
Before the $3.2 billion acquisition of mRNA player Translate Bio Inc (NASDAQ: TBIO) earlier this month, Sanofi SA (NASDAQ: SNY) expressed interest in selling off around 25% of its shares in the
3 Best Biotech Stocks To Buy for Upcoming Catalysts
06:00am, Thursday, 12'th Aug 2021
The next few months are critical for these biotech stocks which could witness a massive increase in their stock prices this year The post 3 Best Biotech Stocks To Buy for Upcoming Catalysts appeared f
Sanofi (SNY) Pompe Disease Drug Receives FDA's Approval
01:53pm, Monday, 09'th Aug 2021
The FDA gives approval to Sanofi's (SNY) Nexviazyme (avalglucosidase alfa) for treating late-onset Pompe disease.
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
09:18am, Thursday, 05'th Aug 2021
The Phase 3 trial of Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo in combination with platinum-doublet chemotherapy was stopped early after meeting its overa
Analysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
02:19am, Thursday, 05'th Aug 2021
Pharmaceutical company Sanofi remains under pressure to launch new drugs and overcome setbacks in the COVID-19 vaccine race, despite a $3.2 billion deal to tighten its grip on promising mRNA technolog
Sanofi to Buy mRNA Developer: ETFs in Focus
04:01pm, Wednesday, 04'th Aug 2021
Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.
The 102 Most Reliable Dividends On Earth For August
10:17am, Wednesday, 04'th Aug 2021
Kiplinger "insights for investors" online first offered a list of 91 "Top Dividend Stocks From Around The World" 7/13/20. Two recent Kiplinger articles provided 102 Top Dividend Stocks on Earth list 7
Delta Variant Surge Brings Biotech ETFs in Focus
06:18pm, Tuesday, 03'rd Aug 2021
The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Translate Bio, Inc.
04:24pm, Tuesday, 03'rd Aug 2021
NEW YORK, Aug. 3, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Translate Bio, Inc. ("Translate" or
Hot Biotech Stocks To Watch After Sanofi's Acquisition Of Translate Bio
11:05am, Tuesday, 03'rd Aug 2021
Biotech stocks surge after big news & bullish analyst ratings. The post Hot Biotech Stocks To Watch After Sanofi's Acquisition Of Translate Bio appeared first on Penny Stocks to Buy, Picks, News and I
Sanofi to buy mRNA developer for $3.2 billion
08:15am, Tuesday, 03'rd Aug 2021
Shares of Translate Bio Inc. soared 29.8% in premarket trading on Tuesday after Sanofi said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares
Why Sanofi (SNY) Is Buying Translate Bio (TBIO) For $3.2 Billion
06:31am, Tuesday, 03'rd Aug 2021
Sanofi SA (NASDAQ: SNY) has announced it is buying Translate Bio (NASDAQ: TBIO) in a deal valued at about $3.2 billion. These are the details.
Sanofi Bets Big On mRNA Push With Translate Bio Acquisition For $3.2B: Highlights
06:04am, Tuesday, 03'rd Aug 2021
A year after paying Translate Bio Inc (NASDAQ: TBIO) a whopping $425 million to develop mRNA vaccines for infectious diseases, including COVID-19, Sanofi SA (NASDAQ: SNY) has announced a $3.2 b
